IVIG Boya: Safety, Efficacy, and Pharmacokinetics

Clinical trial NCT06150833 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06150833
Sponsor: Azidus Brasil
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Disease

Start date: 2026-09-01
Primary completion: 2028-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.